← Eichor
Study identifier: NCT06501430 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effects of Autogenic Inhibition and Reciprocal Inhibition in Amateur Football Players With Shin Splints.

Condition: Shin Splint  ·  Sponsor: Riphah International University

PhaseNA
Planned participants16
Who can joinAll sexes, 18 Years to 30 Years
Healthy volunteersYes

About this study

This randomized controlled trial aims to compare the effectiveness of Autogenic Inhibition and Reciprocal Inhibition in treating shin splints among amateur footballers aged 18-30 from SA Gardens Football Club, Lahore. Participants will be recruited through non-probability convenient sampling and randomly assigned into two groups using random number sampling. A single-blind approach will be employed, with one group receiving Autogenic Inhibition treatment and the other receiving Reciprocal Inhibition treatment over a period of four weeks, with three sessions per week. The study will measure outcomes including pain alleviation, improvement in range of motion (ROM), enhanced function, and improved sports performance. This research seeks to provide insights into the benefits of muscle energy techniques for athletes with shin splints, contributing valuable knowledge to sports medicine and rehabilitation practices.

This description comes directly from the study's public registry record.

Talk to the study team

Zohaib Imran, MS SPT  ·  03099977372  ·  zohaibimran83@gmail.com

Muzna Munir, MS SPT  ·  +923344265125  ·  muznafmh@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Pakistan Sports BoardLahore, Punjab Province, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06501430